BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,301 Cr | ₹1,212 Cr | ₹1,154 Cr | ₹1,109 Cr | ₹1,077 Cr |
What is the latest Total Liabilities ratio of BLISS GVS PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,301 Cr |
| Mar2024 | ₹1,212 Cr |
| Mar2023 | ₹1,154 Cr |
| Mar2022 | ₹1,109 Cr |
| Mar2021 | ₹1,077 Cr |
How is Total Liabilities of BLISS GVS PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,301 Cr | 7.37 | |
| Mar2024 | ₹1,212 Cr | 5.03 | |
| Mar2023 | ₹1,154 Cr | 4.04 | |
| Mar2022 | ₹1,109 Cr | 2.97 | |
| Mar2021 | ₹1,077 Cr | - | |
Compare Total Liabilities of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹2,448.7 Cr | 8% | 41% | 54.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,062.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,192.0 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,129.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,513.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,250.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 8% |
41% |
54.6% |
| SENSEX | -1% |
-0.1% |
7.9% |
You may also like the below Video Courses